Liposomal amphotericin B for pediatric patients with malignant diseases at high risk for invasive fungal infections. Results of a comparing prospective study;Liposomales amphotericin b bei pädiatrisch-onkologischen patienten mit hohem risiko für invasive pilzinfektionen: Ergebnisse einer vergleichenden, prospektiven studie

Krankenhauspharmazie

Volumn 23, Issue 9, 2002, Pages 416-423

  Uhlenbrock, Susanne ^a   Zimmermann, Martin ^a   Kolve, Hedwig ^a   Fegeler, Wolfgang ^a   Jürgens, Heribert ^a   Ritter, Jörg ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Amphotericin B; Antimycotic prophylaxis; Cancer; Children; Liposomal formulation

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CANCER PATIENT; CLINICAL TRIAL; HIGH RISK PATIENT; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MORBIDITY; MORTALITY; MULTICENTER STUDY; MYCOSIS;

EID: 0036740001     PISSN: 01737597     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Trends in postmortem epidemiology of invasive fungal infections at a university hospital
2. Fungal infections in cancer patients: An international autopsy survey
3. Therapie systemischer pilzinfektionen und der einfluß von antimykotika auf das immunsystem
4. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia
5. Empiric antifungal therapy in febrile granulozytopenic patients
6. Diagnosis of systemic fungal infections in hematology. Standard recommendations of the Working Group for Infections in Hematology and Oncology of the German Association for Hematology and Oncology
7. Invasive aspergillosis complicating induction chemotherapy of childhood leukaemia
8. Liposomal amphotericin B (AmBisome): Safety data from a phase II/III clinical trial
9. Liposomal amphotericin B for prophylaxis of invasive fungal infections in high-risk paediatric patients with chemotherapy-related neutropenia: Interim analysis of a prospective study
10. Prävention von pilzinfektionen bei kindern und jugendlichen mit neoplastischen erkrankungen
11. Hämatologie
12. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus
13. Aspects in the diagnosis of deepseated opportunistic mycoses
14. Special aspects related to invasive fungal infections in children with cancer
15. Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: A randomised, double-blind, placebo-controlled study
16. Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients
17. Treatment-related deaths during induction and first remission of acute myeloid leukaemia in children treated on the Tenth Medical Research Council acute myeloid leukaemia trial (MRC AML10)
18. An approach to intensive antileukemia therapy in patients with previous invasive aspergillosis
19. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia